| Literature DB >> 35750714 |
Mahsa Rezazadegan1, Saeideh Mirzaei2, Ali Asadi3, Masoumeh Akhlaghi4, Parvane Saneei5.
Abstract
The relationship between dietary acid load (DAL) and metabolic health status in adolescents has not been studied yet. We aimed to examine the association between DAL and metabolic health status in Iranian overweight/obese adolescents. This cross-sectional study included 203 overweight/obese adolescents selected by a multistage cluster random sampling method. Dietary intakes were assessed using a validated 147-item food frequency questionnaire (FFQ). Anthropometric indices and blood pressure values were measured. Fasting blood samples were obtained to determine glucose, insulin, and lipid profiles. Based on two methods (International Diabetes Federation (IDF) criteria and combination of IDF with Homeostasis Model Assessment Insulin Resistance (HOMA-IR)), participants were classified into metabolically healthy obese (MHO) or unhealthy obese (MUO). Adolescents in the highest tertile of potential renal acid load (PRAL) and net endogenous acid production (NEAP), compared with those in the lowest tertile, had 172% (95% CI 1.32-5.59) and 161% (95% CI 1.26-5.41) higher odds of MUO status, based on IDF criteria. This association was significant after adjustment for age, sex, and energy intake (PRAL: OR 2.42; 95% CI CI 1.13-5.15; NEAP: OR 2.52; 95% CI 1.17-5.41); but it disappeared after adjustment for other confounders. Based on IDF/HOMA-IR definition, there was a significant positive association between PRAL and being MUO only in the crude model (OR 2.37; 95% CI 1.13-4.96). The stratified analysis revealed that these associations for NEAP scores were stronger among overweight subjects than obese individuals, based on both metabolic status definitions. However, after adjustment for all potential confounders these relations were insignificant. Having higher DAL might be associated with higher odds of MUO phenotype in Iranian overweight/obese adolescents. More prospective studies are warranted to confirm this finding.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35750714 PMCID: PMC9232519 DOI: 10.1038/s41598-022-15018-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
General characteristics and cardiometabolic factors of study participants across tertiles of PRAL and NEAP1.
| Tertiles of PRAL | Tertiles of NEAP | |||||||
|---|---|---|---|---|---|---|---|---|
| T1 (n = 67) | T2 (n = 68) | T3 (n = 68) | T1 (n = 67) | T2 (n = 68) | T3 (n = 68) | |||
| Range | < 6.21 | 6.21–17.46 | > 17.46 | – | < 48.52 | 48.52–62.35 | > 62.35 | – |
| Boys | 32 (47.8) | 31 (45.6) | 38 (55.9) | 0.44 | 37 (55.2) | 33 (48.5) | 31 (45.6) | 0.51 |
| Girls | 35 (52.2) | 37 (54.4) | 30 (44.1) | 30 (44.8) | 35 (51.5) | 37 (54.4) | ||
| Age (year) | 14.27 ± 1.73 | 13.68 ± 1.41 | 13.99 ± 1.62 | 0.10 | 13.97 ± 1.73 | 13.78 ± 1.53 | 14.18 ± 1.55 | 0.35 |
| Weight (kg) | 71.06 ± 9.61 | 74.19 ± 12.56 | 75.14 ± 12.15 | 0.10 | 71.23 ± 10.30 | 75.66 ± 12.54 | 73.50 ± 11.57 | 0.08 |
| BMI (kg/m2) | 26.82 ± 2.72 | 27.83 ± 3.95 | 27.39 ± 2.85 | 0.19 | 26.78 ± 2.86 | 28.04 ± 3.85 | 27.22 ± 2.80 | 0.07 |
| Waist circumference (cm) | 88.93 ± 7.31 | 90.82 ± 8.83 | 91.20 ± 7.49 | 0.20 | 89.13 ± 8.74 | 91.64 ± 7.84 | 90.19 ± 7.05 | 0.18 |
| Sedentary | 20 (29.9) | 33 (48.5) | 36 (52.9) | 0.02 | 19 (28.4) | 31 (45.6) | 39 (57.4) | 0.01 |
| Low-activity | 28 (41.8) | 24 (35.3) | 25 (36.8) | 29 (43.3) | 28 (41.2) | 20 (29.4) | ||
| Active | 19 (28.3) | 11 (16.2) | 7 (10.3) | 19 (28.3) | 9 (13.2) | 9 (13.2) | ||
| Low | 16 (23.9) | 13 (19.1) | 30 (44.1) | 0.01 | 14 (20.9) | 17 (25.0) | 28 (41.2) | 0.05 |
| Medium | 31 (46.3) | 37 (54.4) | 22 (32.4) | 30 (44.8) | 32 (47.1) | 28 (41.2) | ||
| High | 20 (29.8) | 18 (26.5) | 16 (23.5) | 23 (34.3) | 19 (27.9) | 12 (17.6) | ||
| Systolic blood pressure (mmHg) | 110.12 ± 24.98 | 113.18 ± 16.83 | 114.78 ± 10.27 | 0.32 | 110.48 ± 24.24 | 114.50 ± 18.07 | 113.10 ± 10.03 | 0.43 |
| Diastolic blood pressure (mmHg) | 71.80 ± 13.04 | 73.96 ± 10.84 | 74.69 ± 10.02 | 0.31 | 71.74 ± 13.14 | 75.41 ± 6.66 | 73.30 ± 12.99 | 0.17 |
| Fasting blood glucose level (mg/dL) | 95.16 ± 7.18 | 98.78 ± 7.81 | 100.41 ± 9.58 | 0.01 | 95.94 ± 7.57 | 98.25 ± 7.27 | 100.18 ± 9.98 | 0.01 |
| Insulin (μUI/mL) | 18.04 ± 12.12 | 20.78 ± 10.49 | 22.40 ± 14.77 | 0.12 | 18.88 ± 12.39 | 21.55 ± 14.43 | 20.81 ± 10.93 | 0.45 |
| HOMA-IR index | 4.34 ± 3.21 | 5.14 ± 2.92 | 5.55 ± 3.58 | 0.09 | 4.58 ± 3.32 | 5.26 ± 3.53 | 5.19 ± 2.96 | 0.41 |
| Triglycerides (mg/dL) | 108.78 ± 58.30 | 117.99 ± 53.61 | 138.90 ± 81.55 | 0.02 | 110.55 ± 60.89 | 123.97 ± 59.77 | 131.16 ± 76.87 | 0.19 |
| HDL cholesterol (mg/dL) | 45.51 ± 8.08 | 44.51 ± 7.36 | 44.46 ± 8.36 | 0.69 | 46.09 ± 7.93 | 43.88 ± 7.27 | 44.51 ± 8.47 | 0.25 |
1Values are Mean ± SD; unless indicated. Abbreviations: NEAP: net endogenous acid production; PRAL: potential renal acid load; BMI: Body Mass Index; HOMA-IR: Homeostasis Model Assessment Insulin Resistance; HDL-c: high-density lipoprotein cholesterol;
2P value for one-way analysis of variance (ANOVA) and χ2 test for quantitative and categorical variables, respectively.
3Socioeconomic status (SES) score was evaluated based on parental education level, parental job, number of family members, having car in the family, having computer/laptop, having personal room and having travel by using demographic questionnaire.
Dietary intakes (energy and macro/micro nutrients) of study participants across tertiles of PRAL and NEAP 1.
| Tertiles of PRAL | Tertiles of NEAP | |||||||
|---|---|---|---|---|---|---|---|---|
| T1 (n = 67) | T2 (n = 68) | T3 (n = 68) | P value2 | T1 (n = 67) | T2 (n = 68) | T3 (n = 68) | P value2 | |
| Range | < 6.21 | 6.21–17.46 | > 17.46 | – | < 48.52 | 48.52–62.35 | > 62.35 | – |
| Energy, kcal | 2756.28 ± 65.80 | 2894.76 ± 65.65 | 2996.16 ± 65.14 | 0.03 | 2826.52 ± 66.50 | 2912.46 ± 66.09 | 2909.26 ± 66.04 | 0.58 |
| Protein, % of E | 13.83 ± 0.24 | 14.22 ± 0.24 | 14.86 ± 0.24 | 0.01 | 14.10 ± 0.24 | 14.47 ± 0.24 | 14.34 ± 0.24 | 0.55 |
| Carbohydrate,% of E | 57.95 ± 0.63 | 57.87 ± 0.63 | 59.03 ± 0.63 | 0.35 | 57.21 ± 0.61 | 57.25 ± 0.60 | 60.39 ± 0.60 | < 0.001 |
| Fat, % of E | 30.00 ± 0.62 | 29.23 ± 0.62 | 27.32 ± 0.62 | 0.01 | 30.53 ± 0.59 | 29.70 ± 0.59 | 26.33 ± 0.59 | < 0.001 |
| Cholesterol, mg | 272.98 ± 12.18 | 290.58 ± 12.04 | 282.50 ± 12.04 | 0.59 | 285.82 ± 11.86 | 302.54 ± 11.77 | 257.88 ± 11.76 | 0.02 |
| SFA, gr | 27.44 ± 0.71 | 28.44 ± 0.70 | 26.17 ± 0.70 | 0.07 | 28.58 ± 0.66 | 28.99 ± 0.66 | 24.50 ± 0.66 | < 0.001 |
| MUFA, gr | 28.99 ± 0.83 | 27.72 ± 0.82 | 25.95 ± 0.82 | 0.03 | 30.06 ± 0.79 | 28.21 ± 0.78 | 24.41 ± 0.78 | < 0.001 |
| PUFA, gr | 29.51 ± 0.98 | 29.12 ± 0.97 | 26.83 ± 0.97 | 0.11 | 29.59 ± 0.97 | 28.92 ± 0.96 | 26.95 ± 0.96 | 0.13 |
| Vitamin C, mg | 180.89 ± 5.90 | 124.83 ± 5.83 | 95.86 ± 5.83 | < 0.001 | 177.71 ± 5.75 | 133.37 ± 5.71 | 90.45 ± 5.70 | < 0.001 |
| Vitamin A, RAE | 1525.04 ± 68.89 | 1011.76 ± 68.11 | 791.61 ± 68.09 | < 0.001 | 1524.40 ± 66.51 | 1073.49 ± 66.02 | 730.50 ± 65.96 | < 0.001 |
| Thiamin, mg | 2.56 ± 0.03 | 2.64 ± 0.03 | 2.73 ± 0.03 | 0.01 | 2.50 ± 0.03 | 2.63 ± 0.03 | 2.79 ± 0.03 | < 0.001 |
| Riboflavin, mg | 2.45 ± 0.06 | 2.35 ± 0.06 | 2.10 ± 0.06 | 0.01 | 2.55 ± 0.06 | 2.41 ± 0.06 | 1.93 ± 0.06 | < 0.001 |
| Niacin, mg | 26.13 ± 0.41 | 27.67 ± 0.40 | 28.87 ± 0.40 | < 0.001 | 25.68 ± 0.37 | 27.41 ± 0.37 | 29.58 ± 0.37 | < 0.001 |
| Vitamin B6, mg | 1.85 ± 0.04 | 1.57 ± 0.04 | 1.44 ± 0.04 | < 0.001 | 1.87 ± 0.04 | 1.68 ± 0.04 | 1.31 ± 0.04 | < 0.001 |
| Vitamin E, mg | 31.47 ± 1.41 | 31.59 ± 1.40 | 28.01 ± 1.40 | 0.12 | 30.37 ± 1.41 | 30.49 ± 1.40 | 30.20 ± 1.40 | 0.99 |
| Folate, mcg | 368.96 ± 11.59 | 305.05 ± 11.46 | 276.63 ± 11.45 | < 0.001 | 381.34 ± 10.51 | 317.89 ± 10.43 | 251.58 ± 10.42 | < 0.001 |
| Vitamin B12, mcg | 4.65 ± 0.18 | 4.61 ± 0.18 | 4.03 ± 0.18 | 0.02 | 4.98 ± 0.16 | 4.70 ± 0.16 | 3.62 ± 0.16 | < 0.001 |
| Magnesium, mg | 323.79 ± 6.94 | 289.48 ± 6.86 | 251.79 ± 6.86 | < 0.001 | 335.58 ± 5.74 | 296.15 ± 5.70 | 233.51 ± 5.69 | < 0.001 |
| Zinc, mg | 10.85 ± 0.28 | 10.79 ± 0.27 | 10.25 ± 0.27 | 0.24 | 11.39 ± 0.25 | 11.08 ± 0.25 | 9.44 ± 0.25 | < 0.001 |
| Selenium, mcg | 0.08 ± 0.01 | 0.09 ± 0.01 | 0.10 ± 0.01 | 0.01 | 0.08 ± 0.01 | 0.09 ± 0.01 | 0.09 ± 0.01 | 0.08 |
| Total fiber, gr | 23.11 ± 0.50 | 18.40 ± 0.50 | 16.87 ± 0.50 | < 0.001 | 23.14 ± 0.48 | 18.85 ± 0.48 | 16.39 ± 0.48 | < 0.001 |
| Sodium, mg | 3764.76 ± 140.53 | 3921.70 ± 138.93 | 4276.50 ± 138.88 | 0.03 | 3743.05 ± 139.80 | 4128.98 ± 138.77 | 4090.60 ± 138.65 | 0.10 |
| Potassium, mg | 4055.15 ± 89.91 | 3358.72 ± 88.88 | 2729.53 ± 88.85 | < 0.001 | 4178.22 ± 72.91 | 3435.63 ± 72.37 | 2531.36 ± 72.31 | < 0.001 |
| `Calcium, mg | 1416.07 ± 41.43 | 1381.51 ± 40.96 | 1215.82 ± 40.95 | 0.01 | 1483.59 ± 38.55 | 1384.78 ± 38.26 | 1146.02 ± 38.23 | < 0.001 |
| Phosphorus, mg | 1514.80 ± 42.17 | 1504.23 ± 41.69 | 1400.54 ± 41.68 | 0.10 | 1617.77 ± 38.03 | 1532.18 ± 37.74 | 1271.14 ± 37.71 | < 0.001 |
1Values are Mean ± SE. Energy intake, and macro-nutrients (protein, carbohydrate and fat) were adjusted for age and gender; all other values were adjusted for age, gender and energy intake. Abbreviations: NEAP: net endogenous acid production; PRAL: potential renal acid load; E: energy intake; SFA, Saturated fatty acids; MUFA, Monounsaturated fatty acids; PUFA, Polyunsaturated fatty acids.
2P value obtained from ANCOVA test.
Figure 1Prevalence of MUO across tertiles of PRAL and NEAP. (A) Based on IDF definition, (B) Based on IDF/HOMA-IR definition.
Multivariate adjusted odds ratio (OR) and 95% confidence interval (CI) for MUO phenotype across tertiles of PRAL and NEAP 1.
| Tertiles of PRAL | Tertiles of NEAP | |||||||
|---|---|---|---|---|---|---|---|---|
| T1 (n = 67) | T2 (n = 68) | T3 (n = 68) | P trend2 | T1 (n = 67) | T2 (n = 68) | T3 (n = 68) | P trend2 | |
| Cases (n) | 18 | 27 | 34 | 17 | 30 | 32 | ||
| Crude | 1 (Ref.) | 1.79 (0.86, 3.70) | 2.72 (1.32, 5.59) | 0.01 | 1 (Ref.) | 2.32 (1.12, 4.81) | 2.61 (1.26, 5.41) | 0.01 |
| Model 1 | 1 (Ref.) | 1.71 (0.79, 3.71) | 2.42 (1.13, 5.15) | 0.02 | 1 (Ref.) | 2.62 (1.20, 5.74) | 2.52 (1.17, 5.41) | 0.02 |
| Model 2 | 1 (Ref.) | 1.18 (0.49, 2.81) | 1.55 (0.65, 3.65) | 0.31 | 1 (Ref.) | 1.97 (0.83, 4.67) | 1.45 (0.61, 3.46) | 0.43 |
| Model 3 | 1 (Ref.) | 1.13 (0.47, 2.71) | 1.55 (0.65, 3.66) | 0.30 | 1 (Ref.) | 1.87 (0.78, 4.49) | 1.47 (0.61, 3.49) | 0.42 |
| Cases (n) | 16 | 22 | 29 | 15 | 26 | 26 | ||
| Crude | 1 (Ref.) | 1.52 (0.71, 3.25) | 2.37 (1.13, 4.96) | 0.02 | 1 (Ref.) | 2.14 (1.01, 4.56) | 2.14 (1.01, 4.56) | 0.05 |
| Model 1 | 1 (Ref.) | 1.34 (0.59, 3.03) | 1.93 (0.88, 4.23) | 0.09 | 1 (Ref.) | 2.56 (1.11, 5.86) | 2.20 (0.97, 4.95) | 0.07 |
| Model 2 | 1 (Ref.) | 0.83 (0.32, 2.10) | 1.16 (0.47, 2.83) | 0.69 | 1 (Ref.) | 1.84 (0.73, 4.64) | 1.21 (0.48, 3.05) | 0.78 |
| Model 3 | 1 (Ref.) | 0.76 (0.29, 1.96) | 1.13 (0.46, 2.79) | 0.70 | 1 (Ref.) | 1.67 (0.65, 4.28) | 1.21 (0.48, 3.07) | 0.76 |
1All values are odds ratios and 95% confidence intervals. Model 1: Adjusted for age, sex, and energy intake. Model 2: Additionally, adjusted for physical activity and socioeconomic status (evaluated based on parental education level, parental job, number of family members, having car in the family, having computer/laptop, having personal room and having travel by using demographic questionnaire). Model 3: Additionally, adjusted for BMI.
2Obtained by the use of tertiles of PRAL or NEAP as an ordinal variable in the model.
Multivariate adjusted odds ratio (OR) and 95% confidence interval (CI) for MUO phenotype across tertiles of PRAL and NEAP, stratified by BMI categories1.
| Tertiles of PRAL | Tertiles of NEAP | |||||||
|---|---|---|---|---|---|---|---|---|
| T1 | T2 | T3 | P-trend2 | T1 | T2 | T3 | P-trend2 | |
| (Participants/cases) | 45/8 | 30/10 | 29/10 | 40/6 | 28/7 | 36/15 | ||
| Crude | 1 (Ref.) | 2.31 (0.78, 6.79) | 2.43 (0.82, 7.18) | 0.09 | 1 (Ref.) | 1.88 (0.55, 6.38) | 4.04 (1.35, 12.06) | 0.01 |
| Model 1 | 1 (Ref.) | 3.22 (0.97, 10.60) | 3.21 (0.97, 10.59) | 0.05 | 1 (Ref.) | 2.39 (0.63, 9.01) | 4.82 (1.47, 15.76) | 0.01 |
| Model 2 | 1 (Ref.) | 2.45 (0.59, 10.15) | 1.86 (0.44, 7.75) | 0.38 | 1 (Ref.) | 1.15 (0.24, 5.39) | 2.03 (0.47, 8.75) | 0.31 |
| (Participants/cases) | 22/10 | 38/17 | 39/24 | 27/11 | 40/23 | 32/17 | ||
| Crude | 1 (Ref.) | 0.97 (0.33, 2.79) | 1.92 (0.66, 5.53) | 0.17 | 1 (Ref.) | 1.96 (0.73, 5.30) | 1.64 (0.58, 4.64) | 0.37 |
| Model 1 | 1 (Ref.) | 0.82 (0.26, 2.53) | 1.51 (0.50, 4.56) | 0.35 | 1 (Ref.) | 2.20 (0.76, 6.34) | 1.48 (0.49, 4.42) | 0.51 |
| Model 2 | 1 (Ref.) | 0.54 (0.15, 1.95) | 0.89 (0.24, 3.23) | 0.98 | 1 (Ref.) | 2.41 (0.74, 7.87) | 1.11 (0.32, 3.84) | 0.92 |
| (Participants/cases) | 45/6 | 30/7 | 29/7 | 40/4 | 28/5 | 36/11 | ||
| Crude | 1 (Ref.) | 1.97 (0.59, 6.60) | 2.06 (0.61, 6.93) | 0.22 | 1 (Ref.) | 1.95 (0.47, 8.05) | 3.96 (1.13, 13.86) | 0.02 |
| Model 1 | 1 (Ref.) | 2.67 (0.70, 10.20) | 2.52 (0.66, 9.52) | 0.17 | 1 (Ref.) | 2.75 (0.57, 13.21) | 4.96 (1.23, 19.89) | 0.02 |
| Model 2 | 1 (Ref.) | 1.92 (0.38, 9.66) | 1.13 (0.24, 5.34) | 0.91 | 1 (Ref.) | 1.06 (0.17, 6.58) | 1.44 (0.26, 7.71) | 0.62 |
| (Participants/cases) | 22/10 | 38/15 | 39/22 | 27/11 | 40/21 | 32/15 | ||
| Crude | 1 (Ref.) | 0.78 (0.27, 2.26) | 1.55 (0.54, 4.44) | 0.30 | 1 (Ref.) | 1.60 (0.59, 4.31) | 1.28 (0.45, 3.61) | 0.67 |
| Model 1 | 1 (Ref.) | 0.61 (0.19, 1.93) | 1.15 (0.38, 3.50) | 0.60 | 1 (Ref.) | 1.81 (0.62, 5.23) | 1.15 (0.38, 3.48) | 0.85 |
| Model 2 | 1 (Ref.) | 0.38 (0.10, 1.46) | 0.70 (0.19, 2.58) | 0.80 | 1 (Ref.) | 2.01 (0.61, 6.59) | 0.87 (0.25, 3.07) | 0.75 |
1All values are odds ratios and 95% confidence intervals. Model 1: Adjusted for age, sex, and energy intake. Model 2: Additionally, adjusted for physical activity and socioeconomic status (evaluated based on parental education level, parental job, number of family members, having car in the family, having computer/laptop, having personal room and having travel by using demographic questionnaire).
2Obtained by the use of tertiles of PRAL or NEAP as an ordinal variable in the model.